The tri-state area's best subcontractor – specializing in Spray Fireproofing, Intumescent Paint, and Spray Insulation. We work on commercial and industrial projects ranging from high-rises to shopping centers, providing fire-rated assemblies, and applying spray insulation. To see the full list of services we offer please visit our website. We aim to provide quality service at a competitive price! We work to provide the highest quality. We aim to deliver a competitive price. Safety is always our #1 priority!

Advanced Materials Technology is an innovative product development and manufacturing company in the separation sciences focused on groundbreaking technology to solve the unsolvable! From pioneering Fused-Core® technology with the first commercially available sub 3um particle, the HALO® product line has revolutionized HPLC separations. With over 120 years of ingenuity in design and manufacturing, AMT continues to be a leader in novel superficially porous particle development enabling high efficiency and reliability for scientists involved in both small and large molecule separations.

Aquatrols is a specialty chemical company engaged in the discovery, development and commercialization of uniquely effective products and formulation technologies. These technologies provide water, energy, labor and other resource savings for the turf, ornamental, agricultural and snowmaking industries worldwide.

At Verrica Pharmaceuticals, we are dedicated to easing the strain of hard-to-treat viral skin infections affecting millions of underserved patients. We are initially developing a topical therapy for the treatment of molluscum contagiosum, a highly contagious and primarily pediatric viral skin disease, and common warts. There is currently no FDA-approved treatment nor is there an established standard of care for either of these diseases, resulting in significant undertreated populations in two of the largest unmet needs in dermatology. Headquartered in West Chester, Pennsylvania, Verrica was founded in 2013. We are led by a seasoned management team with extensive pharmaceutical industry experience ranging from drug development through commercialization and collectively launched more than 50 products.

Amring Pharmaceuticals is a privately held pharmaceutical company that provides value brands and niche generics to the market. The company is part of Sever Life Sciences, BV and is partnered with well-established global biopharmaceutical companies. Amring is uniquely positioned to leverage its partners’ expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.

CONDOR TECHNOLOGIES INC is a company based out of 110 N MAIN ST SUITE H, CAMDEN, Delaware, United States.

Marlex Pharmaceuticals,Inc provides over 100 products consisting of Generic, Consumer, and Specialty Pharmaceuticals. Our products are distributed through wholesalers for hospital, nursing homes, and home health use across the U.S. Marlex Pharmaceuticals Inc. was first established in 1992 and has offered the highest quality pharmaceutical products and excellent customer service.

At LAVA, we are focused on applying our expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy. We refer to our compounds as gamma-delta bispecific T-cell engagers, or gamma-delta bsTCEs. Our platform generates therapeutics that specifically activate a unique and relatively abundant effector gamma-delta T-cell subset called Vγ9Vδ2 (Vgamma9-Vdelta2) T-cells that have the ability to trigger activity of immune cells of both the innate and adaptive immune system. Our gamma-delta bsTCEs have demonstrated superior efficacy and safety profiles compared to other bsTCE approaches in preclinical studies and show preferential activity against tumor cells thereby potentially limiting toxicity in healthy tissue. To date, we are the only company developing bispecific gamma-delta T-cell engaging antibodies for the treatment of cancer. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor specific antigen CD1d, which can be overexpressed in multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), among other tumor types. LAVA-051 will enter a Phase I/IIa study in 1Q21.

GSD Chem, Inc, manufactures and sells specialty cleaning formulations and lubricants. The company serves several key markets, including: - Food Manufacturing, Preparation & Distribution - Transportation - Industrial Manufacturing - Metalworking - Surface Cleaning/Protection

Founded in 1910 as American Solder & Flux Co., we are a specialty chemical manufacturing company, supplying superior products to the metal working industry. Our primary business is the manufacture of fluxes and metal lubricants. Our fluxes are used in ferrous and nonferrous joining activities such as aluminum soldering and brazing; silver brazing of brass, bronze, steel, etc.; and brazing of steel and cast iron. Our customers are located on five continents; our business is global. AMCO fluxes and lubricants are used in industries as varied as aerospace, automotive, beverage, HVAC, lighting, plumbing, roofing and telecommunications. With nearly 200 active formulations, we offer solutions to your soldering, brazing, welding, slitting and stamping needs.

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s lead assets originated from the Pleotherapy™ R&D approach. Pharnext draws the attention of investors to the financial and other risk factors detailed in its financial reports. More information can be found at www.pharnext.com. Pharnext is listed on the Euronext Growth Stock Exchange in Paris.

We specialize in Blending and Packaging (Liquid and Powder) for the following industries: -Water Treatment -Industrial Cleaning -Food Plant Cleaning -Janitorial